Navigation Links
Eisai Inc. and the Alzheimer's Association Honor Community Pharmacist for Outstanding Service to Individuals with Alzheimer's Disease
Date:10/29/2009

WOODCLIFF LAKE, N.J., Oct. 29 /PRNewswire/ -- Eisai Inc. and the Alzheimer's Association announce today that Heather Greene, PharmD is the recipient of the 2009 C.A.R.E. Pharmacy Award.

(Photo: http://www.newscom.com/cgi-bin/prnh/20091029/NY00986 )

Dr. Greene is being recognized for the critical role she has played in helping patients and caregivers fight Alzheimer's disease. As a Geriatric Consultant Pharmacist with the Riverside Health System at the Richmond PACE (Program of All-inclusive Care for the Elderly) facility, she is a member of an interdisciplinary team that provides care for some of the area's frailest seniors. In the nomination for her work with Alzheimer's disease patients and caregivers, Dr. Greene was described as someone "who goes far beyond being a pharmacist when she works with patients and their families"... "a caring person, a knowledgeable pharmacist, an excellent trainer and educator, and a dedicated volunteer." She received her Doctor of Pharmacy degree from the School of Pharmacy at Virginia Commonwealth University in Richmond, VA.

The C.A.R.E. Pharmacy Award recognizes the extraordinary impact that pharmacists can have on the lives of individuals with Alzheimer's disease and their families. Now in its ninth year, the award is a reflection of Eisai's human health care (hhc) mission, which is to give first thought to patients and their families, and to increasing the benefits that health care provides.

"Alzheimer's is a devastating disease for individuals as well as for their caregivers and family members," said Cynthia Schwalm, President, U.S. Pharmaceuticals, Eisai Inc. "Eisai recognizes the integral role pharmacists play in each patient's treatment and care, through ongoing monitoring, counseling and support. We are proud to honor this year's C.A.R.E. award recipient for her invaluable contributions to enhance the quality of care for people affected by Alzheimer's disease."

"As a member of the C.A.R.E. Pharmacy Award selection committee, I saw the impressive contributions of nominated pharmacists who work as a part of a cohesive team of care providers for people with Alzheimer's disease," said Elizabeth Gould, MSW, LCSW, director of quality care programs for the Alzheimer's Association. "We applaud this year's winner on her extraordinary efforts in building a relationship with those living with Alzheimer's and their caregivers, helping to educate them about Alzheimer's disease and enhancing the support they receive."

A $1,500 donation will be made to the Greater Richmond Alzheimer's Association Chapter, which serves the area where the award recipient resides, and also to the Massachusetts/New Hampshire and Greater Illinois Alzheimer's Association Chapters in recognition of having the most award nominations submitted from within their service areas.

About Eisai Inc.

Eisai Inc. is a wholly-owned subsidiary of Eisai Corporation of North America. Established in 1995 and ranked among the top-20 U.S. pharmaceutical companies (based on retail sales), the company began marketing its first product in the United States in 1997 and has rapidly grown to become a fully integrated pharmaceutical business with fiscal year 2008 (year ended March 31, 2009) sales of approximately $3.7 billion. Eisai Inc.'s areas of commercial focus include neurology, gastrointestinal disorders and oncology/critical care. The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Headquartered in Woodcliff Lake, New Jersey, Eisai Inc. has several R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as well as manufacturing facilities in Maryland and North Carolina. For more information about Eisai, please visit www.eisai.com.

About the Alzheimer's Association

The Alzheimer's Association is the leading voluntary health organization in Alzheimer's research, care and support. Our mission is to eliminate Alzheimer's disease through the advancement of research, provide and enhance care and support for all affected, and reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. For more information, visit www.alz.org.

SOURCE Eisai Inc.


'/>"/>
SOURCE Eisai Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
2. Eisais Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
3. Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting
4. Confusion over Influenzinum Clarified by the American Association of Homeopathic Pharmacists (AAHP)
5. American Association for Homecare Proposes Strong Anti-Fraud Measures in Medicare, Applauds HHS Testimony Today That Pledges to "Stop Fraud Before it Starts"
6. American Lung Association of California Joins Sheriffs Department to Support Influenza Vaccination In Sacramento
7. Ikaria Receives Award for Excellence by New Jersey Business & Industry Association
8. American Association for Homecare Backs Bipartisan Bill to Eliminate Medicare Bidding Program for Home Medical Equipment
9. American Hospital Association (AHA) Names OnBase RACTrac Compatible
10. American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver
11. American Lung Association of the Mid-Atlantic Kicks Off 2009-2010 Faces of Influenza Campaign in Philadelphia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)... April 19, 2017  New research provides evidence that an ... according to a study released today that will be presented ... in Boston , April 22 to ... treatment of Parkinson,s disease, the oral drug levodopa has long ... longevity. But as the disease progresses, the effects of the ...
Breaking Medicine Technology:
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Brady ... announced that its B-595 and B-7569 vinyl label materials received ... and warning labels are tested to remain intact and legible, for use on chemical ...
(Date:4/21/2017)... Colo. (PRWEB) , ... April 21, 2017 , ... The ... the Flex House, the next project in the company’s esteemed VISION House demonstration project ... homeowners use exactly the amount of resources they need to live affordably and abundantly ...
(Date:4/21/2017)... ... ... The Hong Kong Polytechnic University (PolyU) launched today the University Research Facility in ... Kong to support teaching, learning and research. It is also the largest research centre ... Kong. , With an area of 620 square metres and more than 50 ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Alive ... people who wish to overcome their mental health struggles. The Alive team uses ... LeBouthillier says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens ... of International Trade, the UK’s most prestigious award for business success. The ... of total revenues and has grown by a total of 400% over the ...
Breaking Medicine News(10 mins):